ExpreS2ion Biotech Holding AB banner

ExpreS2ion Biotech Holding AB
F:5JD0

Watchlist Manager
ExpreS2ion Biotech Holding AB Logo
ExpreS2ion Biotech Holding AB
F:5JD0
Watchlist
Price: 0.0816 EUR -4.23%
Market Cap: €288k

Wall St Price Targets

5JD0 Price Targets Summary
ExpreS2ion Biotech Holding AB

There are no price targets for 5JD0.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
ExpreS2ion Biotech Holding AB Competitors:
Price Targets

Revenue
Forecast

N/A
Past Growth
39% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
39% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

The compound annual growth rate for Revenue over the next 3 years is 39%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for ExpreS2ion Biotech Holding AB

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
24%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
24%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 5JD0's stock price target?
Not Available

5JD0 does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for ExpreS2ion Biotech Holding AB?
Projected CAGR
39%

The compound annual growth rate for Revenue over the next 3 years is 39%.

Back to Top